Order Article Reprints

Tovar-Nieto AM, Flores-Padilla LE, Rivas-Santiago B, Trujillo-Paez JV, Lara-Ramirez EE, Jacobo-Delgado YM, López-Ramos JE, Rodríguez-Carlos A. The Repurposing of FDA-Approved Drugs as FtsZ Inhibitors against Mycobacterium tuberculosis: An In Silico and In Vitro Study. Microorganisms. 2024; 12(8):1505. https://doi.org/10.3390/microorganisms12081505

Tovar-Nieto, Andrea Michel, Luis Enrique Flores-Padilla, Bruno Rivas-Santiago, Juan Valentin Trujillo-Paez, Edgar Eduardo Lara-Ramirez, Yolanda M. Jacobo-Delgado, Juan Ernesto López-Ramos, and Adrián Rodríguez-Carlos. 2024. "The Repurposing of FDA-Approved Drugs as FtsZ Inhibitors against Mycobacterium tuberculosis: An In Silico and In Vitro Study" Microorganisms 12, no. 8: 1505. https://doi.org/10.3390/microorganisms12081505

Tovar-Nieto, A. M., Flores-Padilla, L. E., Rivas-Santiago, B., Trujillo-Paez, J. V., Lara-Ramirez, E. E., Jacobo-Delgado, Y. M., López-Ramos, J. E., & Rodríguez-Carlos, A. (2024). The Repurposing of FDA-Approved Drugs as FtsZ Inhibitors against Mycobacterium tuberculosis: An In Silico and In Vitro Study. Microorganisms, 12(8), 1505. https://doi.org/10.3390/microorganisms12081505